Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.68MXN
−3.21 BMXN
14.67 BMXN
327.73 M
About Opko Health, Inc.
Sector
Industry
CEO
Phillip Frost
Website
Headquarters
Miami
Employees (FY)
3.93 K
Founded
1991
FIGI
BBG00JX0PYG2
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
NASDAQ:OPK - OPKO Health, Inc. - Game On !!!NASDAQ:OPK
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers l
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OPK is 15.38 MXN — it has decreased by 9.53% in the past 24 hours. Watch OPKO HEALTH, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange OPKO HEALTH, INC stocks are traded under the ticker OPK.
OPKO HEALTH, INC is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
OPK stock is 10.68% volatile and has beta coefficient of 2.02. Track OPKO HEALTH, INC stock price on the chart and check out the list of the most volatile stocks — is OPKO HEALTH, INC there?
OPK earnings for the last quarter are −1.99 MXN per share, whereas the estimation was −1.58 MXN resulting in a −25.85% surprise. The estimated earnings for the next quarter are −1.71 MXN per share. See more details about OPKO HEALTH, INC earnings.
OPKO HEALTH, INC revenue for the last quarter amounts to 2.88 B MXN despite the estimated figure of 3.03 B MXN. In the next quarter revenue is expected to reach 3.13 B MXN.
Yes, you can track OPKO HEALTH, INC financials in yearly and quarterly reports right on TradingView.
OPK stock has risen by 0.13% compared to the previous week, the month change is a 0.13% rise, over the last year OPKO HEALTH, INC has showed a 11.00% decrease.
OPK net income for the last quarter is −1.36 B MXN, while the quarter before that showed −1.13 B MXN of net income which accounts for −20.06% change. Track more OPKO HEALTH, INC financial stats to get the full picture.
Today OPKO HEALTH, INC has the market capitalization of 14.73 B, it has decreased by 4.53% over the last week.
No, OPK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPKO HEALTH, INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 9, 2024, the company has 3.93 K employees. See our rating of the largest employees — is OPKO HEALTH, INC on this list?
We've gathered analysts' opinions on OPKO HEALTH, INC future price: according to them, OPK price has a max estimate of 143.00 MXN and a min estimate of 25.24 MXN. Watch OPK chart and read a more detailed OPKO HEALTH, INC stock forecast: see what analysts think of OPKO HEALTH, INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPKO HEALTH, INC EBITDA is −1.57 B MXN, and current EBITDA margin is −6.11%. See more stats in OPKO HEALTH, INC financial statements.